MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Net Block History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Block | ₹18,620 Cr | ₹19,004 Cr | ₹4,540 Cr | ₹4,245 Cr | ₹3,583 Cr |
What is the latest Net Block ratio of MANKIND PHARMA ?
| Year | Net Block |
|---|---|
| Mar2026 | ₹18,620 Cr |
| Mar2025 | ₹19,004 Cr |
| Mar2024 | ₹4,540 Cr |
| Mar2023 | ₹4,245 Cr |
| Mar2022 | ₹3,583 Cr |
How is Net Block of MANKIND PHARMA Trending?
| Years | Net Block | % Change | |
|---|---|---|---|
| Mar2026 | ₹18,620 Cr | -2.02 | |
| Mar2025 | ₹19,004 Cr | 318.61 | |
| Mar2024 | ₹4,540 Cr | 6.94 | |
| Mar2023 | ₹4,245 Cr | 18.49 | |
| Mar2022 | ₹3,583 Cr | - | |
Compare Net Block of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹94,521.2 Cr | -1.9% | -5.8% | -12.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹440,278.0 Cr | -3% | -5.2% | 17.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹243,966.0 Cr | 0.2% | 9.7% | 56.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,478.0 Cr | 1.3% | 2% | 36.5% | Stock Analytics | |
| CIPLA | ₹109,950.0 Cr | -2.2% | -6.6% | -10.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,967.4 Cr | 1.4% | -3.7% | -8.8% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | -1.9% |
-5.8% |
-12.9% |
| SENSEX | -2.8% |
-5.2% |
-8.4% |
You may also like the below Video Courses